Company Filing History:
Years Active: 2011-2021
Title: L Nathan Tumey: Innovator in Antibody Engineering
Introduction
L Nathan Tumey is a notable inventor based in Pawcatuck, CT (US). He has made significant contributions to the field of biotechnology, particularly in the development of engineered antibodies. With a total of 3 patents, Tumey's work focuses on advancing therapeutic agents that can improve patient outcomes.
Latest Patents
One of Tumey's latest patents is titled "Engineered antibody constant regions for site-specific conjugation and methods and uses therefor." This invention is directed towards antibodies and antigen-binding portions that are engineered to introduce amino acids for site-specific conjugation. The invention encompasses engineered antibody constant region polypeptides and antibodies comprising these polypeptides. Additionally, it relates to Fc fusion proteins that include an engineered Fc region, as well as methods and uses for producing antibody-drug conjugate therapeutics.
Another significant patent involves a series of compounds that are useful as therapeutic agents. These compounds, specifically thiophenyl and pyrrolyl azepine compounds, act as serotonin receptor (5-HT) ligands. They are designed to treat various diseases and conditions, including addiction, anxiety, depression, and obesity, by modulating the activity of serotonin receptors.
Career Highlights
Throughout his career, L Nathan Tumey has worked with prominent companies in the biotechnology sector. He has been associated with Athersys, Inc. and Pfizer Corporation, where he has contributed to innovative research and development projects. His expertise in antibody engineering has positioned him as a valuable asset in the industry.
Collaborations
Tumey has collaborated with notable professionals in his field, including David C Bom and Youssef L Bennani. These collaborations have further enhanced his research and development efforts, leading to advancements in therapeutic technologies.
Conclusion
L Nathan Tumey's contributions to the field of biotechnology, particularly in engineered antibodies, have made a significant impact on therapeutic development. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient care.